Mechanisms of Myofibre Death in Muscular Dystrophies: The Emergence of the Regulated Forms of Necrosis in Myology
Open accessThe DOI matches its Crossref record; 234 of the 234 references it cites were found in a registry or an index.
Abstract
Myofibre necrosis is a central pathogenic process in muscular dystrophies (MD). As post-lesional regeneration cannot fully compensate for chronic myofibre loss, interstitial tissue accumulates and impairs muscle function. Muscle regeneration has been extensively studied over the last decades, however, the pathway(s) controlling muscle necrosis remains largely unknown. The recent discovery of several regulated cell death (RCD) pathways with necrotic morphology challenged the dogma of necrosis as an uncontrolled process, opening interesting perspectives for many degenerative disorders. In this review, we focus on how cell death affects myofibres in MDs, integrating the latest research in the cell death field, with specific emphasis on Duchenne muscular dystrophy, the best-known and most common hereditary MD. The role of regulated forms of necrosis in myology is still in its infancy but there is increasing evidence that necroptosis, a genetically programmed form of necrosis, is involved in muscle degenerating disorders. The existence of apoptosis in myofibre demise will be questioned, while other forms of non-apoptotic RCDs may also have a role in myonecrosis, illustrating the complexity and possibly the heterogeneity of the cell death pathways in muscle degenerating conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Local and systemic toxicity due to snakebite envenomation is primarily driven by cytotoxic venom components that affect cell viability and extracellular matrix degradation [4,26].”
From Role of Regulated Cell Death Pathways in Snakebite Envenomation: Mechanisms, Crosstalk, and Therapeutic Opportunities (2026) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Disruption of intracellular ion balance, particularly calcium ion imbalance, is a hallmark of venom-induced toxicity [26].”
From Role of Regulated Cell Death Pathways in Snakebite Envenomation: Mechanisms, Crosstalk, and Therapeutic Opportunities (2026) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These cellular responses then lead to a point of no return that transitions from sublethal cellular injury to a defined form of regulated cell death (RCD), such as apoptosis, ferroptosis, and pyroptosis [26].”
From Role of Regulated Cell Death Pathways in Snakebite Envenomation: Mechanisms, Crosstalk, and Therapeutic Opportunities (2026) · cites this paper as [26]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–234 of 234
Bougé, A.-L., Murauer, E. M., Beyne, E., Miro, J., Varilh, J., Taulan‐Cadars, M., Koenig, M., Claustres, M., & Tuffery‐Giraud, S. (2017) · Scientific Reports · doi:10.1038/srep39094 · Cited by 34
Dubinin, M. V., Starinets, V. S., Talanov, E. Y., Mikheeva, I. B., Belosludtseva, N. V., & Belosludtsev, K. N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189780 · Cited by 34
The peculiar apoptotic behavior of skeletal muscle cells.
Salucci, S., Burattini, S., Baldassarri, V., Battistelli, M., Canonico, B., Valmori, A., Papa, S., & Falcieri, E. (2013) · PubMed · doi:10.14670/hh-28.1073 · Cited by 33
Borok, M. J., Didier, N., Gattazzo, F., Ozturk, T., Corneau, A., Rouard, H., & Relaix, F. (2021) · Cells · doi:10.3390/cells10040744 · Cited by 33
Clinical, morphological and immunological evaluation of six patients with dysferlin deficiency
Prelle, A. C., Sciacco, M., Tancredi, L., Fagiolari, G., Comi, G. P., Ciscato, P., Serafini, M., Fortunato, F., Zecca, C., Gallanti, A., et al. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0654-1 · Cited by 32
Griffin, M. A., Feng, H., Tewari, M., Acosta, P., Kawana, M., Sweeney, H. L., & Discher, D. E. (2005) · Journal of Cell Science · doi:10.1242/jcs.01717 · Cited by 28 · cited 3×
“Regardless of mechanical stress, the intensity of TUNEL cell death assays is spontaneously upregulated in γ-SG KO myotube compared to WT [94], indicating DNA fragmentation and apoptotic-like cell death features.”
BackgroundHarandi, V. M., Oliveira, B. M. S., Allamand, V., Friberg, A., de Oliveira, C. C. F., & Durbeej, M. (2020) · Antioxidants · doi:10.3390/antiox9030244 · Cited by 28
Raffaghello, L., Principi, E., Baratto, S., Panicucci, C., Pintus, S., Antonini, F., Zotto, G. D., Benzi, A., Bruzzone, S., Scudieri, P., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15010089 · Cited by 28 · cited 1×
“Beyond the role of SG in the integrity of sarcolemma, SG exerts an ecto-ATPase activity which is depleted in SG deficient cells, dependent on the P2X7 purinoreceptor [97,98].”
BackgroundDRP-1-mediated apoptosis induces muscle degeneration in dystrophin mutants
Scholtes, C., Bellemin, S., Martin, E., Carre-Pierrat, M., Mollereau, B., Gieseler, K., & Walter, L. (2018) · Scientific Reports · doi:10.1038/s41598-018-25727-8 · Cited by 27
The incidence of necrosis of muscle fibers in Duchenne type muscular dystrophy.
Gilbert, R. K., & Hawk, W. A. (1963) · PubMed · Cited by 27
Cross Talk proposal: Myonuclei are lost with ageing and atrophy
Kirby, T. J., & Dupont‐Versteegden, E. E. (2022) · The Journal of Physiology · doi:10.1113/jp282380 · Cited by 23
Caspase signaling, a conserved inductive cue for metazoan cell differentiation
Burgon, P. G., & Megeney, L. A. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.11.009 · Cited by 23
Muscle Diversity, Heterogeneity, and Gradients: Learning from Sarcoglycanopathies
Riera, C. S., Lozanoska‐Ochser, B., Testa, S., Fornetti, E., Bouché, M., & Madaro, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052502 · Cited by 22
Stressed-out ROS take a silent death route
Kesavardhana, S., & Kanneganti, T. (2018) · Nature Immunology · doi:10.1038/s41590-017-0034-6 · Cited by 20 · cited 1×
“Reactive oxygen species (ROS) are often associated with myofibre death [25,26], even if their precise role in pathogenesis remains unclear as ROS can be generated by cells submitted to sublethal or lethal stress [27].”
BackgroundProgrammed Cell Death Pathways in the Pathogenesis of Idiopathic Inflammatory Myopathies
Shi, J., Tang, M., Zhou, S., Xu, D., Zhao, J., Wu, C., Wang, Q., Tian, X., Li, M., & Zeng, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.783616 · Cited by 18
Immunolabelling Myofiber Degeneration in Muscle Biopsies
Bencze, M., Periou, B., Baba‐Amer, Y., & Authier, F. (2019) · Journal of Visualized Experiments · doi:10.3791/59754 · Cited by 18 · cited 1×
“This includes the infiltration of dead myofibres by phagocytic cells (necroinflammation), followed by muscle regeneration [24].”
BackgroundSelf-citationRIPK3‐mediated cell death is involved in DUX4‐mediated toxicity in facioscapulohumeral dystrophy
Mariot, V., Joubert, R., Gall, L. L., Sidlauskaite, E., Hourdé, C., Duddy, W. J., Voït, T., Bencze, M., & Dumonceaux, J. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12813 · Cited by 17 · cited 2×
“Cell death cannot be prevented in caspase-compromised conditions, indicating a non-apoptotic mechanism [17].”
BackgroundSelf-citationBell, R. A. V., Al-Khalaf, M. H., Brunette, S., Alsowaida, D., Chu, A., Bandukwala, H., Dechant, G., Apostolova, G., Dilworth, F. J., & Megeney, L. A. (2022) · Cells · doi:10.3390/cells11060966 · Cited by 17
Loss of cIAP1 attenuates soleus muscle pathology and improves diaphragm function in mdx mice
Enwere, E. K., Boudreault, L., Holbrook, J., Timusk, K., Earl, N., LaCasse, E. C., Renaud, J., & Korneluk, R. G. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds493 · Cited by 16 · cited 1×
“Indeed, RG Korneluk and colleagues elegantly showed that cellular inhibitor of apoptosis (cIAP)1 depletion reduces overall pathology, including myonecrosis in some muscle groups of mdx mice such as the soleus and diaphragm [70].”
BackgroundM1 Macrophages Are More Susceptible to Necroptosis
Hao, Q., Idell, S., & Tang, H. (2021) · Journal of Cellular Immunology · doi:10.33696/immunology.3.084 · Cited by 16
Ortiz‐Cordero, C., Bincoletto, C., Dhoke, N. R., Selvaraj, S., Magli, A., Zhou, H., Kim, D., Bang, A. G., & Perlingeiro, R. C. R. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.09.009 · Cited by 15
Suppression of the necroptotic cell death pathways improves survival in Smn2B/− mice
Chehadé, L., Deguise, M., Repentigny, Y. D., Yaworski, R., Beauvais, A., Gagnon, S., Hensel, N., & Kothary, R. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.972029 · Cited by 15
Loss of membrane integrity drives myofiber death in lipin1‐deficient skeletal muscle
Sattiraju, S. R., Jama, A., Alshudukhi, A. A., Townsend, N. E., Miranda, D. R., Reese, R., Voss, A. A., & Ren, H. (2020) · Physiological Reports · doi:10.14814/phy2.14620 · Cited by 15
Further considerations on in vitro skeletal muscle cell death
Battistelli, M., Salucci, S., Burattini, S., & Falcieri, E. (2019) · Muscles Ligaments and Tendons Journal · doi:10.32098/mltj.04.2013.06 · Cited by 14
Danielsson, O., Häggqvist, B., Gröntoft, L., Öllinger, K. M., & Ernerudh, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239176 · Cited by 12
Bencze, M., Periou, B., Punzón, I., Barthélémy, I., Taglietti, V., Hou, C., Zaidan, L. R., Kefi, K., Blot, S., Agbulut, O., et al. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13265 · Cited by 10
Self-citationLau, Y. S., Zhao, L., Zhang, C., Bailin, P. L., & Han, R. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118069 · Cited by 9
Cohen, L., Morgan, J. P., & Bozyk, M. E. (1977) · PubMed · Cited by 9
Hou, C., Periou, B., Gervais, M., Berthier, J., Baba‐Amer, Y., Souvannanorath, S., Malfatti, E., Relaix, F., Bencze, M., & Authier, F. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.16.472927 · Cited by 7
Self-citationImmunolabelling Myofiber Degeneration in Muscle Biopsies
Bencze, M., Periou, B., Baba-Amer, Y., & Authier, F. J. (2019) · Journal of Visualized Experiments · doi:10.3791/59754-v · Cited by 7
Self-citationDubinin, M. V., Starinets, V. S., Mikheeva, I. B., & Belosludtsev, K. N. (2022) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-022-05459-6 · Cited by 6
Effect of pretreatment with prednisolone on enzyme efflux from isolated skeletal and heart muscle.
Cohen, L., Morgan, J. P., & Bozyk, M. E. (1975) · PubMed · Cited by 5
Bencze, M., Periou, B., Punzón, I., Barthélémy, I., Taglietti, V., Hou, C., Zaidan, L., Kefi, K., Blot, S., Agbulut, O., et al. (2022) · doi:10.1101/2022.01.06.475271 · Cited by 1
Self-citationAngelini, C., Huertas, M. L., Rodriguez-Mora, S., & Alcami, J. (2021) · Neuromuscular Disorders · doi:10.1016/j.nmd.2021.07.199
Cited by
Tejedera‐Villafranca, A., Montolio, M., Ramón‐Azcón, J., & Fernández‐Costa, J. M. (2023) · Biofabrication · doi:10.1088/1758-5090/acfb3d · Cited by 21
“This represents a significant milestone as it provides an opportunity to explore the replication of additional manifestations of DMD stemming from a sarcolemmal injury, thereby initiating cellular degeneration and eventual muscle wasting [51].”
BackgroundNieves‐Rodriguez, S., Barthélémy, F., Woods, J. D., Douine, E. D., Wang, R. T., Scripture-Adams, D. D., Chesmore, K. N., Galasso, F. I., Miceli, M. C., & Nelson, S. F. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1216066 · Cited by 19
“Myofiber death in DMD has been mainly attributed to necrosis (Bencze, 2023).”
BackgroundKirby, T. J., Zahr, H. C., Fong, E. H. H., & Lammerding, J. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01998-1 · Cited by 14
“For ex vivo contraction studies, post-mortem tissue was obtained from animals sacri fi ced for other approved research projects and/or breeding surplus of the VU University in accordance with the European Council Directive (2010/63/EU) by permission of the Animal Research Law of the Netherlands.”
MethodThe Gut Microbiota Involvement in the Panorama of Muscular Dystrophy Pathogenesis
Russo, C., Surdo, S., Valle, M. S., & Malaguarnera, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011310 · Cited by 12
“In the early stages, due to the regenerative capabilities of muscle fibers, the microlesions may be associated with pseudo-muscle hypertrophy, especially in postural muscles such as the sural triceps [55].”
BackgroundBencze, M., Periou, B., Punzón, I., Barthélémy, I., Taglietti, V., Hou, C., Zaidan, L. R., Kefi, K., Blot, S., Agbulut, O., et al. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13265 · Cited by 10
Self-citation
Metadata
- Authors
- Bencze, M.
- Affiliations
- Inserm (FR)
- Corresponding author
- Bencze, Maximilien
- ORCID
- Bencze, Maximilien
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-12-26
- Volume
- 24
- Issue
- 1
- Pages
- 362
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9820579
- OpenAlex
- W4313245546
- Cited by
- 20
- References
- 232
- Citations by year
- 2026: 8 · 2025: 4 · 2024: 3 · 2023: 5
- FWCI
- 0.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Association Française contre les Myopathies (AFM-Téléthon) (#19507, #22946)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- muscular dystrophy, regulated cell death, necroptosis, apoptosis, Duchenne muscular dystrophy, muscle degeneration, muscle regeneration, muscle necrosis, interstitial fibrosis
- MeSH terms
- Humans, Necrosis, Apoptosis, Muscle, Skeletal, Muscular Dystrophy, Duchenne
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.